U.S. Markets close in 6 hrs 30 mins

Why 22nd Century Group Inc (NYSEMKT:XXII) Could Be A Buy

Seth Doty

22nd Century Group Inc (AMEX:XXII), a tobacco company based in United States, saw a decent share price growth in the teens level on the AMEX over the last few months. Less-covered, small caps sees more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Today I will analyse the most recent data on 22nd Century Group’s outlook and valuation to see if the opportunity still exists. View our latest analysis for 22nd Century Group

What’s the opportunity in 22nd Century Group?

The stock seems fairly valued at the moment according to my relative valuation model. I’ve used the price-to-book ratio in this instance because there’s not enough visibility to forecast its cash flows, and its earnings doesn’t seem to reflect its true value. The stock’s ratio of 3.81x is currently trading slightly above its industry peers’ ratio of 3.46x, which means if you buy 22nd Century Group today, you’d be paying a relatively reasonable price for it. And if you believe 22nd Century Group should be trading in this range, then there isn’t really any room for the share price grow beyond what it’s currently trading. Although, there may be an opportunity to buy in the future. This is because 22nd Century Group’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What does the future of 22nd Century Group look like?

AMEX:XXII Future Profit May 10th 18

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Though in the case of 22nd Century Group, it is expected to deliver a negative revenue growth of -9.35% next year, which doesn’t help build up its investment thesis. It appears that risk of future uncertainty is high, at least in the near term.

What this means for you:

Are you a shareholder? XXII seems fairly priced right now, but given the uncertainty from negative returns in the future, this could be the right time to de-risk your portfolio. Is your current exposure to the stock beneficial for your total portfolio? And is the opportunity cost of holding a negative-outlook stock too high? Before you make a decision on XXII, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping an eye on XXII for a while, now may not be the most optimal time to buy, given it is trading around its fair value. The stock appears to be trading at fair value, which means there’s less benefit from mispricing. In addition to this, the negative growth outlook increases the risk of holding the stock. However, there are also other important factors we haven’t considered today, which can help crystalize your views on XXII should the price fluctuate below its true value.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on 22nd Century Group. You can find everything you need to know about 22nd Century Group in the latest infographic research report. If you are no longer interested in 22nd Century Group, you can use our free platform to see my list of over 50 other stocks with a high growth potential.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.